To include your compound in the COVID-19 Resource Center, submit it here.

AM-Pharma completes Phase II enrollment of recAP in AKI

AM-Pharma B.V. (Bunnik, the Netherlands) completed enrollment of 301 patients in the Phase II

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE